Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in DMAC held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | COOPERMAN LEON G | 2.0M | $13.7M | 0.0% | 3.749% | 0.45% |
| 2 | BlackRock, Inc. | 1.9M | $12.6M | -2.4% | 3.445% | 0.00% |
| 3 | MILLENNIUM MANAGEMENT LLC | 936K | $6.3M | +21.7% | 1.736% | 0.00% |
| 4 | PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 875K | $5.9M | 0.0% | 1.624% | 8.05% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 781K | $5.3M | +2.1% | 1.448% | 0.00% |
| 6 | STATE STREET CORP | 644K | $4.4M | +2.6% | 1.196% | 0.00% |
| 7 | FIRST MANHATTAN CO | 455K | $3.1M | +12.3% | 0.844% | 0.01% |
| 8 | Bleichroeder LP | 382K | $2.6M | 0.0% | 0.710% | 0.45% |
| 9 | NORTHERN TRUST CORP | 339K | $2.3M | +4.0% | 0.628% | 0.00% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 333K | $2.3M | — | 0.619% | 0.00% |
| 11 | ADVISOR GROUP HOLDINGS, INC. | 320K | $2.2M | +29.4% | 0.593% | 0.00% |
| 12 | LPL Financial LLC | 226K | $1.5M | +14.7% | 0.419% | 0.00% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLC | 203K | $1.4M | — | 0.378% | 0.00% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 188K | $1.3M | — | 0.348% | 0.00% |
| 15 | SEI INVESTMENTS CO | 111K | $754K | +100.0% | 0.207% | 0.00% |
| 16 | Bank of New York Mellon Corp | 111K | $752K | -8.2% | 0.206% | 0.00% |
| 17 | MORGAN STANLEY | 105K | $714K | -80.8% | 0.196% | 0.00% |
| 18 | MEMBERS WEALTH LLC | 101K | $656K | 0.0% | 0.188% | 0.39% |
| 19 | EAM Investors, LLC | 91K | $619K | 0.0% | 0.170% | 0.07% |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 88K | $599K | -8.7% | 0.164% | 0.00% |
| 21 | Nuveen, LLC | 79K | $536K | -28.7% | 0.147% | 0.00% |
| 22 | MAGNOLIA CAPITAL ADVISORS LLC | 77K | $524K | 0.0% | 0.144% | 0.10% |
| 23 | Blue Trust, Inc. | 69K | $468K | 0.0% | 0.128% | 0.01% |
| 24 | Kalehua Capital Management LLC | 62K | $423K | -34.5% | 0.116% | 0.36% |
| 25 | ExodusPoint Capital Management, LP | 60K | $406K | — | 0.111% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in DMAC — a direct measure of their conviction.
Filings activity in DMAC during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 95 | +4.4% | 25.49% | 5.68 pp | $78M | 18% |
| Q4 2025 | 91 | +20% | 31.17% | +4.24 pp | $95M | +16% |
| Q3 2025 | 76 | +29% | 26.93% | +14.88 pp | $82M | +123% |
| Q2 2025 | 59 | +3.5% | 12.05% | +2.89 pp | $37M | +32% |
| Q1 2025 | 57 | +27% | 9.16% | 2.74 pp | $28M | 23% |
| Q4 2024 | 45 | +13% | 11.90% | +4.26 pp | $36M | +56% |
| Q3 2024 | 40 | +29% | 7.64% | +2.66 pp | $23M | +54% |
| Q2 2024 | 31 | — | 4.98% | — | $15M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying DMAC stock.
Based on Q1 2026 13F filings, institutional ownership of DiaMedica Therapeutics Inc. stands at 25.5%, held across 95 reporting institutions.
COOPERMAN LEON G is the largest reported institutional holder of DMAC, with approximately 2,020,000 shares worth $0.01B as of Q1 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of DMAC, including MILLENNIUM MANAGEMENT LLC.
Our composite Smart Money Score for DMAC is 41 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
19 institutions opened new positions in DMAC during Q1 2026, while 15 fully exited. 17 added to existing positions and 58 trimmed.
DMAC institutional ownership fell by 5.68 percentage points quarter-over-quarter, with a net change of +4 holders.
The top 10 institutions account for 75.2% of all reported 13F value in DMAC, and the top 25 account for 91.7%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
DiaMedica Therapeutics Inc. (DMAC) Institutional Ownership